000 01352 a2200361 4500
005 20250516193231.0
264 0 _c20140929
008 201409s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0087542
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBjörklund, Emmelie
245 0 0 _aKetoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrations.
_h[electronic resource]
260 _bPloS one
_c2014
300 _ae87542 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmidohydrolases
_xantagonists & inhibitors
650 0 4 _aAnalysis of Variance
650 0 4 _aArachidonic Acids
_xmetabolism
650 0 4 _aCaco-2 Cells
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEndocannabinoids
_xmetabolism
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aKetoconazole
_xpharmacology
650 0 4 _aPolyunsaturated Alkamides
_xmetabolism
650 0 4 _aReceptor, Cannabinoid, CB2
_xmetabolism
700 1 _aLarsson, Therése N L
700 1 _aJacobsson, Stig O P
700 1 _aFowler, Christopher J
773 0 _tPloS one
_gvol. 9
_gno. 1
_gp. e87542
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0087542
_zAvailable from publisher's website
999 _c23488113
_d23488113